Sabra Health Care REIT Statistics
Total Valuation
SBRA has a market cap or net worth of $4.40 billion. The enterprise value is $6.73 billion.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | May 16, 2025 |
Share Statistics
SBRA has 237.94 million shares outstanding. The number of shares has increased by 1.90% in one year.
Current Share Class | 237.94M |
Shares Outstanding | 237.94M |
Shares Change (YoY) | +1.90% |
Shares Change (QoQ) | +0.27% |
Owned by Insiders (%) | 1.59% |
Owned by Institutions (%) | 96.50% |
Float | 234.07M |
Valuation Ratios
The trailing PE ratio is 30.87 and the forward PE ratio is 25.42. SBRA's PEG ratio is 2.76.
Price/FFO Ratio | 13.10 |
Price/AFFO Ratio | n/a |
PE Ratio | 30.87 |
Forward PE | 25.42 |
PS Ratio | 5.96 |
Forward PS | 5.78 |
PB Ratio | 1.61 |
P/TBV Ratio | 1.63 |
P/FCF Ratio | n/a |
P/OCF Ratio | 12.92 |
PEG Ratio | 2.76 |
Financial Ratio History Enterprise Valuation
EV / Earnings | 47.81 |
EV / Sales | 9.34 |
EV / EBITDA | 15.58 |
EV / EBIT | 25.23 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.89.
Current Ratio | 0.85 |
Quick Ratio | 0.36 |
Debt / Equity | 0.89 |
Debt / EBITDA | 5.55 |
Debt / FCF | n/a |
Interest Coverage | 2.35 |
Financial Efficiency
Return on equity (ROE) is 5.15% and return on invested capital (ROIC) is 3.22%.
Return on Equity (ROE) | 5.15% |
Return on Assets (ROA) | 3.14% |
Return on Invested Capital (ROIC) | 3.22% |
Return on Capital Employed (ROCE) | 5.20% |
Revenue Per Employee | $14.40M |
Profits Per Employee | $2.82M |
Employee Count | 50 |
Asset Turnover | 0.14 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, SBRA has paid $965,000 in taxes.
Income Tax | 965,000 |
Effective Tax Rate | 0.68% |
Stock Price Statistics
The stock price has increased by +23.54% in the last 52 weeks. The beta is 0.81, so SBRA's price volatility has been lower than the market average.
Beta (5Y) | 0.81 |
52-Week Price Change | +23.54% |
50-Day Moving Average | 17.83 |
200-Day Moving Average | 17.70 |
Relative Strength Index (RSI) | 57.53 |
Average Volume (20 Days) | 2,488,869 |
Short Selling Information
The latest short interest is 19.26 million, so 8.10% of the outstanding shares have been sold short.
Short Interest | 19.26M |
Short Previous Month | 20.54M |
Short % of Shares Out | 8.10% |
Short % of Float | 8.23% |
Short Ratio (days to cover) | 7.13 |
Income Statement
In the last 12 months, SBRA had revenue of $720.25 million and earned $140.76 million in profits. Earnings per share was $0.60.
Revenue | 720.25M |
Gross Profit | 487.83M |
Operating Income | 266.72M |
Pretax Income | 54.12M |
Net Income | 140.76M |
EBITDA | 432.05M |
EBIT | 266.72M |
Earnings Per Share (EPS) | $0.60 |
Full Income Statement Balance Sheet
The company has $37.89 million in cash and $2.40 billion in debt, giving a net cash position of -$2.36 billion or -$9.94 per share.
Cash & Cash Equivalents | 37.89M |
Total Debt | 2.40B |
Net Cash | -2.36B |
Net Cash Per Share | -$9.94 |
Equity (Book Value) | 2.70B |
Book Value Per Share | 11.36 |
Working Capital | -15.97M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 338.01M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 67.73%, with operating and profit margins of 37.03% and 19.54%.
Gross Margin | 67.73% |
Operating Margin | 37.03% |
Pretax Margin | 19.68% |
Profit Margin | 19.54% |
EBITDA Margin | 59.99% |
EBIT Margin | 37.03% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 6.49%.
Dividend Per Share | $1.20 |
Dividend Yield | 6.49% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 200.43% |
Buyback Yield | -1.90% |
Shareholder Yield | 4.64% |
Earnings Yield | 3.22% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for SBRA is $19.71, which is 6.66% higher than the current price. The consensus rating is "Buy".
Price Target | $19.71 |
Price Target Difference | 6.66% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 7.44% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |